Irrevocable undertakingAsahi Kasei Corp • June 4th, 2024 • American depositary receipts
Offer to Purchase for Cash All Outstanding Shares of Common Stock of ZOLL Medical Corporation at $93.00 Net Per Share by Asclepius Subsidiary Corporation an indirect wholly-owned subsidiary of Asahi Kasei Corporation THE OFFER AND WITHDRAWAL RIGHTS...Asahi Kasei Corp • March 26th, 2012 • American depositary receipts
Asclepius Subsidiary Corporation, a Massachusetts corporation (“Purchaser”) and an indirect wholly-owned subsidiary of Asahi Kasei Corporation, a corporation organized in Japan (“Asahi Kasei”), hereby offers to purchase all issued and outstanding shares of common stock, par value $0.01 (the “Shares”), including the associated preferred stock purchase rights issued under the Shareholder Rights Agreement (as described in this Offer to Purchase), of ZOLL Medical Corporation, a Massachusetts corporation (“ZOLL”), at a price of $93.00 per Share, net to the seller in cash (the “Offer Price”), without interest thereon and less any required withholding taxes, upon the terms and subject to the conditions set forth in this Offer to Purchase and in the related Letter of Transmittal (which, together with any amendments or supplements thereto, collectively constitute the “Offer”).
ASAHI KASEI CORPORATIONAsahi Kasei Corp • April 3rd, 2012 • American depositary receipts
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • July 18th, 2024 • Asahi Kasei Corp • American depositary receipts • Stockholm
CALLIDITAS THERAPEUTICS, AB, a Swedish corporation with its registered office and mailing address at PO Box 70351, SE-107 24 Stockholm, Sweden and its principal office and address for courier delivery at Kungsbron 1, D5, SE 11122 Stockholm, Sweden (“CALLIDITAS”), and
